TSHA
Taysha Gene Therapies Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating | ||||||
| Operating Cash Flow | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — |
| Investing | ||||||
| Capital Expenditures | 738,000 | 374,000 | 3.9M | 20.6M | 15.3M | 82,000 |
| Acquisitions | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — |
| Financing | ||||||
| Debt Repayment | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — |
| Summary | ||||||
| Free Cash Flow | -93.8M | -81.6M | -76.9M | -109.0M | -132.3M | -30.8M |
| Net Change in Cash | — | — | — | — | — | — |